Belong rolls out online community for patients with CML

January 13, 2022.

Patients can use the service to access support groups, navigation tools and a clinical trial-matching program. Oncology-focused social media platform Belong.Life is launching a new online community dedicated to individuals living with chronic myeloid leukemia. The community, which will be hosted on the Belong-Beating Cancer Together app, will include support groups, navigation tools about the condition and access to professionals.

Users can tap into the service to help organize their medical records and participate in a clinical trial matching program. Patients are able to track their symptoms and condition over time through the service.

Why it Matters –

According to the American Cancer Society, in 2022 about 8,860 individuals will be diagnosed with chronic myeloid leukemia, and 1,220 people will die of the condition. The condition makes up roughly 15% of all new leukemia cases, and is more likely to impact older people. In fact, according to the society, the average age of a diagnosis is 64 years.

Belong.Life is pitching its new service as a way for patients to get more engaged with their health.

“We are proud to launch this vital community,” Dr. Daniel Vorobiof, chief medical director of Belong.Life, said in a statement. “Our aim is to provide the largest engagement and education network for CML patients and caregivers in the United States. Our customized CML tool, in conjunction with our proven personalized platform with strong AI and real-world research capabilities, will enhance engagement and real-life treatment journeys for our users.”

Continue reading >

More Articles

Dave AI on TIME’s Best Inventions of 2024 List

Dave AI is one of groundbreaking innovations recognized in TIME’s ‘Best Inventions of 2024 …

Belong Honored as a Top Oncology Solution Provider Transforming Healthcare

Belong.Life is one of the “Starts Us Insights” 8 top oncology solutions impacting the…

The Best Inventions of 2024

At times when doctors aren’t available, people with cancer can turn to Dave — an…
Skip to content